117 related articles for article (PubMed ID: 6193874)
1. Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors.
Markus G; Camiolo SM; Kohga S; Madeja JM; Mittelman A
Cancer Res; 1983 Nov; 43(11):5517-25. PubMed ID: 6193874
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activators in human malignant melanoma.
Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues.
Camiolo SM; Markus G; Englander LS; Siuta MR; Hobika GH; Kohga S
Cancer Res; 1984 Jan; 44(1):311-8. PubMed ID: 6197164
[TBL] [Abstract][Full Text] [Related]
4. Localization of plasminogen activators in human colon cancer by immunoperoxidase staining.
Kohga S; Harvey SR; Weaver RM; Markus G
Cancer Res; 1985 Apr; 45(4):1787-96. PubMed ID: 3884145
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification.
Corasanti JG; Celik C; Camiolo SM; Mittelman A; Evers JL; Barbasch A; Hobika GH; Markus G
J Natl Cancer Inst; 1980 Aug; 65(2):345-51. PubMed ID: 6931252
[TBL] [Abstract][Full Text] [Related]
6. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas.
Pyke C; Salo S; Ralfkiaer E; Rømer J; Danø K; Tryggvason K
Cancer Res; 1995 Sep; 55(18):4132-9. PubMed ID: 7664291
[TBL] [Abstract][Full Text] [Related]
7. Secretion of plasminogen activators by human colorectal and gastric tumor explants.
Harvey SR; Lawrence DD; Madeja JM; Abbey SJ; Markus G
Clin Exp Metastasis; 1988; 6(6):431-50. PubMed ID: 3409559
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma.
Festuccia C; Vincentini C; di Pasquale AB; Aceto G; Zazzeroni F; Miano L; Bologna M
Oncol Res; 1995; 7(3-4):131-8. PubMed ID: 8555646
[TBL] [Abstract][Full Text] [Related]
9. Molecular species of plasminogen activators secreted by normal and neoplastic human cells.
Wilson EL; Becker ML; Hoal EG; Dowdle EB
Cancer Res; 1980 Mar; 40(3):933-8. PubMed ID: 7193517
[TBL] [Abstract][Full Text] [Related]
10. Content and characterization of plasminogen activators in human lung tumors and normal lung tissue.
Markus G; Takita H; Camiolo SM; Corasanti JG; Evers JL; Hobika GH
Cancer Res; 1980 Mar; 40(3):841-8. PubMed ID: 7193515
[TBL] [Abstract][Full Text] [Related]
11. Secretion of proteinases from malignant and nonmalignant human breast tissue.
Recklies AD; Tiltman KJ; Stoker TA; Poole AR
Cancer Res; 1980 Mar; 40(3):550-6. PubMed ID: 6258782
[TBL] [Abstract][Full Text] [Related]
12. Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness.
Mira-y-Lopez R; Ossowski L
Cancer Res; 1987 Jul; 47(13):3558-64. PubMed ID: 3107811
[TBL] [Abstract][Full Text] [Related]
13. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M
Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
[TBL] [Abstract][Full Text] [Related]
14. Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72 kDa gelatinase.
Shah V; Kumar S; Zirvi KA
In Vivo; 1994; 8(3):321-6. PubMed ID: 7803712
[TBL] [Abstract][Full Text] [Related]
15. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
[TBL] [Abstract][Full Text] [Related]
16. Identification of markers of possible prognostic value in 57 giant cell tumors of bone.
Gamberi G; Serra M; Ragazzini P; Magagnoli G; Pazzaglia L; Ponticelli F; Ferrari C; Zanasi M; Bertoni F; Picci P; Benassi MS
Oncol Rep; 2003; 10(2):351-6. PubMed ID: 12579271
[TBL] [Abstract][Full Text] [Related]
17. Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype.
Swiercz R; Wolfe JD; Zaher A; Jankun J
Clin Cancer Res; 1998 Apr; 4(4):869-77. PubMed ID: 9563880
[TBL] [Abstract][Full Text] [Related]
18. Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1.
Jänicke F; Pache L; Schmitt M; Ulm K; Thomssen C; Prechtl A; Graeff H
Cancer Res; 1994 May; 54(10):2527-30. PubMed ID: 8168072
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic enzymes in tumor metastasis. I. Plasminogen activator in clones of Lewis lung carcinoma and T10 sarcoma.
Eisenbach L; Segal S; Feldman M
J Natl Cancer Inst; 1985 Jan; 74(1):77-85. PubMed ID: 3855489
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of urokinase-type plasminogen activator in human gliomas.
Hsu DW; Efird JT; Hedley-Whyte ET
Am J Pathol; 1995 Jul; 147(1):114-23. PubMed ID: 7604873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]